HIMS
xyz:
equity
· Hyperliquid
—
Equity perp — Hyperliquid synthetic derivative. For real-time exchange pricing, turn off the Crypto toggle and search the bare equity ticker.
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. Hims & Hers Health, Inc. is based in San Francisco, California.
Mark Price
$29.69
24h Change
+7.96%
Funding (8h)
+0.0049%
Open Interest
125,640
24h Volume
$1.32M
Oracle Price
$29.66
Mark − Oracle
+0.0637%
Prev Day Close
$27.50
As of (UTC)
2026-06-15 18:48:39
Daily candles — last 83 days
Funding rate history — last 7 days (8h cycles)
Positive funding = longs paying shorts (long-crowded). Negative = shorts paying longs (short-crowded).
Peers — same category
| Coin | Mark | 24h % |
|---|---|---|
| SPCX | $187.16 | +12.69% |
| MU | $1095.30 | +8.69% |
| SNDK | $2103.30 | +4.92% |
| SKHX | $1591.20 | +6.15% |
| INTC | $127.94 | +0.04% |
News headlines Yahoo Finance, 1h cache
-
HIMS Stock Set To Test A Crucial Resistance – Is Retail Expecting A Breakout?
2026-06-15 17:56 · Yahoo
-
Fuel Up Your Portfolio with Suja Life’s Farm-to-Bottle Growth Strategy
2026-06-15 15:52 · Yahoo
-
Doximity (DOCS) Up 11.2% Since Last Earnings Report: Can It Continue?
2026-06-12 15:30 · Yahoo
-
The GLP-1 stock nobody is pricing in isn’t a drugmaker
2026-06-11 13:30 · Yahoo
-
Hims And Hers Expands Benefits As Investors Weigh Overvaluation And Volatility
2026-06-11 06:12 · Yahoo
-
Why Hims & Hers Health, Inc. (HIMS) Dipped More Than Broader Market Today
2026-06-10 21:45 · Yahoo
-
OMCL vs. HIMS: Which Stock Is the Better Value Option?
2026-06-10 15:40 · Yahoo
-
Hims & Hers Health (HIMS) Up 15.8% Since Last Earnings Report: Can It Continue?
2026-06-10 15:30 · Yahoo
-
Investors Heavily Search Hims & Hers Health, Inc. (HIMS): Here is What You Need to Know
2026-06-08 13:00 · Yahoo
-
Is Hims & Hers Health, Inc. (HIMS) A Good Stock To Buy Now?
2026-06-07 14:52 · Yahoo